Trial record 2 of 7 for:    pazopanib GIST

Pazopanib in Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors (GIST)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2012 by Stanford University.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Kristen Ganjoo, Stanford University
ClinicalTrials.gov Identifier:
NCT01391611
First received: July 8, 2011
Last updated: December 12, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)